Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Analysts

Stevanato Group S.p.A. (NYSE:STVN) has earned an average rating of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company.

A number of analysts recently weighed in on STVN shares. William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th. Bank of America increased their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, December 13th. UBS Group dropped their target price on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a report on Friday, March 7th. Morgan Stanley restated an “equal weight” rating and set a $23.00 target price (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, Wolfe Research started coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an “outperform” rating and a $28.00 target price on the stock.

Hedge Funds Weigh In On Stevanato Group

Several hedge funds have recently made changes to their positions in the business. Hardy Reed LLC grew its stake in shares of Stevanato Group by 8.2% during the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares in the last quarter. First Bank & Trust grew its stake in shares of Stevanato Group by 7.3% in the fourth quarter. First Bank & Trust now owns 15,145 shares of the company’s stock valued at $330,000 after buying an additional 1,036 shares in the last quarter. Truist Financial Corp grew its stake in shares of Stevanato Group by 4.2% in the fourth quarter. Truist Financial Corp now owns 26,900 shares of the company’s stock valued at $586,000 after buying an additional 1,073 shares in the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of Stevanato Group by 9.7% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 12,874 shares of the company’s stock valued at $281,000 after buying an additional 1,141 shares in the last quarter. Finally, US Bancorp DE grew its stake in shares of Stevanato Group by 17.9% in the fourth quarter. US Bancorp DE now owns 8,527 shares of the company’s stock valued at $186,000 after buying an additional 1,295 shares in the last quarter.

Stevanato Group Stock Performance

Stevanato Group stock opened at €22.52 ($24.48) on Friday. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group has a 1 year low of €16.56 ($18.00) and a 1 year high of €33.49 ($36.40). The company has a market cap of $6.82 billion, a PE ratio of 47.91, a PEG ratio of 7.18 and a beta of 0.60. The company’s 50-day moving average is €21.03 and its two-hundred day moving average is €20.59.

Stevanato Group (NYSE:STVN) last released its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.22). The company had revenue of €352.68 million for the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Equities analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.